MYD Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Myriad Genetics Inc

Watchlist Manager

Watchlist

Price: 3.252 EUR -0.58%

Market Cap: €292.4m

M	Myriad Genetics Inc DUS:MYD	US
	Cytek Biosciences Inc F:8EQ	US
P	Petroleo Brasileiro SA Petrobras SWB:PJXC	BR
	MacroGenics Inc NASDAQ:MGNX	US
	Virgin Galactic Holdings Inc F:0QL	US
	Freshworks Inc F:7DF	US
	SOL SpA F:QOL	IT
N	Northern Trust Corp F:NT4	US
A	Asahi Kasei Corp XMUN:ASAA	JP
T	Takeda Pharmaceutical Co Ltd XHAM:TKD	JP
D	Darden Restaurants Inc XMUN:DDN	US
	Daimler Truck Holding AG F:DTG1	DE

Profitability Summary

Myriad Genetics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

70%

Strong 3Y Average Gross Margin

69%

Gross Margin is Increasing

69% > 70%

Negative Operating Margin

-8%

Negative 3Y Average Operating Margin

-14%

Operating Margin is Increasing

-23% > -8%

Negative Net Margin

-48%

Negative 3Y Average Net Margin

-32%

Declining Net Margin

-21% > -48%

Negative Free Cash Flow Margin

-3%

Negative 3Y Average Free Cash Flow Margin

-11%

Free Cash Flow Margin is Increasing

-22% > -3%

Negative ROE

-77%

Negative 3Y Average ROE

Negative 3Y Average ROIC